Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bielack

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Klinische Padiatrie|July 1, 1989
[Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years]S Bielack, J Beck, G Delling, et al.
Cancer Treatment and Research|March 10, 2010
International collaboration is feasible in trials for rare conditions: the EURAMOS experienceN Marina, S Bielack, J Whelan, et al.
Pediatric Blood & Cancer|June 1, 2005
Concomitant Ewing sarcoma and acute lymphoblastic leukemia in a 5-year-old girlKatja Masjosthusmann, Stefan S Bielack, Gabriele Köhler, et al.
Journal of Cancer Research and Clinical Oncology|October 2, 2024
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatmentStefan S Bielack, Carole Soussain, Christopher P Fox, et al.
Cancer Medicine|August 5, 2024
Beyond 5-year survival. A report from the Cooperative Osteosarcoma Study Group (COSS)Julia S Fernandes, Claudia Blattmann, Stefanie Hecker-Nolting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Prognostic relevance of increased angiogenesis in osteosarcomaMichael Kreuter, Ralf Bieker, Stefan S Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Clinico-histologic parameters of osteosarcoma patients with late relapseE I Hauben, S Bielack, R Grimer, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1990
Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary resultsK Winkler, S Bielack, G Delling, et al.
Pediatric Blood & Cancer|October 6, 2005
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trialsMerle Eselgrim, Henrike Grunert, Thomas Kühne, et al.
Pediatric Blood & Cancer|January 22, 2011
Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS)Sabine Stegmaier, Christopher Poremba, Karl-Ludwig Schaefer, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Klinische Padiatrie|July 1, 1989
[Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years]S Bielack, J Beck, G Delling, et al.
Cancer Treatment and Research|March 10, 2010
International collaboration is feasible in trials for rare conditions: the EURAMOS experienceN Marina, S Bielack, J Whelan, et al.
Pediatric Blood & Cancer|June 1, 2005
Concomitant Ewing sarcoma and acute lymphoblastic leukemia in a 5-year-old girlKatja Masjosthusmann, Stefan S Bielack, Gabriele Köhler, et al.
Journal of Cancer Research and Clinical Oncology|October 2, 2024
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatmentStefan S Bielack, Carole Soussain, Christopher P Fox, et al.
Cancer Medicine|August 5, 2024
Beyond 5-year survival. A report from the Cooperative Osteosarcoma Study Group (COSS)Julia S Fernandes, Claudia Blattmann, Stefanie Hecker-Nolting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Prognostic relevance of increased angiogenesis in osteosarcomaMichael Kreuter, Ralf Bieker, Stefan S Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Clinico-histologic parameters of osteosarcoma patients with late relapseE I Hauben, S Bielack, R Grimer, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1990
Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary resultsK Winkler, S Bielack, G Delling, et al.
Pediatric Blood & Cancer|October 6, 2005
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trialsMerle Eselgrim, Henrike Grunert, Thomas Kühne, et al.
Pediatric Blood & Cancer|January 22, 2011
Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS)Sabine Stegmaier, Christopher Poremba, Karl-Ludwig Schaefer, et al.
Pageof 19